BSE filing, BSE: 530805. Summary written from the filing by ALFA Finder's alert engine.
Onesource Industries and Ventures Ltd: key numbers
- Share price
- ₹3.02
- Market cap
- ₹9.29 Cr
- Revenue (annual)
- ₹99.45 Cr
- Net profit (annual)
- ₹2.65 Cr
- P/E (TTM)
- 6.7×Sector 43.1×
- Promoter holding
- 28.98%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Onesource Industries and Ventures Ltd
All →Onesource Industries and Ventures Other Announcement
Onesource Industries And Ventures Ltd has submitted its quarterly shareholding pattern filing for the quarter ended September 30, 2026, in compliance with SEBI Listing Regulations.
Onesource Industries and Ventures Annual General Meeting
Onesource Industries And Ventures Limited held its 32nd Annual General Meeting on September 30, 2026. The meeting successfully transacted all ordinary and special businesses listed.
Onesource Industries and Ventures Capital Structure Change
Onesource Industries and Ventures Limited approved a Rights Issue of equity shares. Terms including price and quantity remain subject to finalization at a later stage.
Onesource Industries and Ventures Fund Raise of ₹52.45 Cr
Onesource Industries approved a rights issue for up to ₹52.45 Crore. The board also approved a new work order for a digital marketplace project.
- Value
- ₹52.45 Cr
Onesource Industries and Ventures Other Announcement
Onesource Industries and Ventures Limited has dispatched annual report access links to shareholders, in compliance with Regulation 36(1)(b) of SEBI LODR Regulations.
Onesource Industries and Ventures Annual General Meeting
The company issued a notice for its 32nd Annual General Meeting to be held on September 30, 2026, via video conferencing and other audio-visual means.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.